65,437 trials
Mental Health · Psychotic Disorders
Primary: Change in Site-level Rates of Weight Monitoring at Baseline (Within 30 Days of a New Antipsychotic Prescription) — 1811; 1410; 1598; 1109 Participants
Giant Cell Arteritis
Primary: Number of Patients That Have Achieved Complete Remission of Disease — 17; 4 Participants — p=0.0301
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Primary: Proportion Of Participants With Normalization Of Lactate Dehydrogenase (LDH) Levels — 0.536; 0.494 proportion of participants
Pathologic Processes
Primary: Major Discordance Rate — 4.4; 4.7 percentage of major discordance
Opioid Use Disorder
Primary: Proportion of Subjects Who Receive and Tolerate a VIVITROL Injection on Day 8 — 35; 38 Participants — p=0.407
Critical Illness · Chronic Disease · Terminal Care
Primary: Occurrence of Discussion About Goals of Care at Target Visit — 137; 66; 47; 145 Participants — p=<0.001
Asthma
Primary: Percentage of Patients With Suspected Adverse Drug Reactions (ADRs) — 5.59 Percentage of participants
Anesthesia, General
Primary: Mean Time From Start of Study Treatment Administration to Recovery of the T4/T1 Ratio to 0.9 — 108.43; 44.73; 6.93; 2.40 minutes
Osteopenia · Bone Turnover Markers · Quality of Life
Primary: Variation in Serum Levels of Procollagen 1 N-terminal Peptide (P1NP) — 58.34; 57.91 mcg/L — p=0.05
Psychomotor Impairment
Primary: Psychomotor Impairment (Driving) — 3.38; -1.54 change in kph
CRC
Primary: Performance of MCS in Cleansing a Poorly Prepared Colon. — 46; 9 Participants — p=<0.01
Cesarean Section
Primary: Induction to Delivery Interval — 268; 276 seconds
Psychomotor Agitation
Primary: Postoperative Agitation — 46; 86 participants with agitation
Acne Vulgaris
Primary: Number of Participants Satisfied and Very Satisfied With Regimen — 42 participants
Hypertension
Primary: Systolic Blood Pressure — 143.5; 143.7 mmHg